ProSomnus Sleep Technologies designs, manufactures and markets highly customizable precision intraoral medical devices that dentists use to treat patients diagnosed with Obstructive Sleep Apnea. The company’s flagship products are the ProSomnus [IA] and MicrO2 ® Snore Devices. They are FDA Cleared Class II Medical Devices that are smaller, stronger, more biocompatible, and more precise than predicate intraoral sleep apnea devices, allowing dentists to get patients into therapy faster, and with greater comfort and convenience. They have been used to treat thousands of patients, with clinical performance that has been validated in randomize controlled trials, retrospective cohort studies, and numerous clinical case reports.
The company is dedicated to further advancing the treatment of obstructive sleep apnea through ongoing research, product development, and process enhancement for improved effectiveness, efficiency, and convenience for patients and doctors alike.
ProSomnus is focused on commercializing device designs that are clinically relevant, creating treatment experiences that exceed the needs of the practicing sleep dentist and his or her patients, and supporting scientific research that further establishes dental sleep medicine as a viable therapy for OSA.
In the end, it is the people of ProSomnus that makes this company great. Passionate about improving and saving lives, our team infuses their care and enthusiasm into every product, strategy, and support system.